ETFIQData as of Nov 19, 2026. · etfiq.com/funds/bmed

BMED Fact Sheet: iShares Health Innovation Active ETF

Share
$34.31
close, Nov 20, 2026

Over the year to Nov 19, 2026, BMED returned +18.6% in total and charged 0.55% a year.

1-year total return
+17.5%
to Nov 20, 2026
Expense ratio
0.55%
a year
Net assets
$14m
on Nov 19, 2026
Net flow, last 5 trading days
$0
daily basis to Nov 19, 2026

Growth of $10,000, 1 year

BMED $11,855 +18.6% · ACWI $10,902 +9.0% · Total return, distributions reinvested, Nov 19, 2025 to Nov 19, 2026.

Returns

WindowTotal return
1 month−3.8%
3 months−0.8%
Year to date+13.5%
1 year+17.5%
3 years+56.6%
5 years+18.5%

Total return, distributions reinvested, each window to Nov 20, 2026.

Ten largest positions

HoldingWeight
GILEAD SCIENCES6.01%
DANAHER5.22%
ABBVIE4.91%
MODERNA4.83%
THERMO FISHER SCIENTIFIC4.41%
EDWARDS LIFESCIENCES4.35%
BIOGEN3.82%
METTLER-TOLEDO INTERNATIONAL INC3.73%
IQVIA HOLDINGS INC3.50%
VERTEX PHARMACEUTICALS3.35%

BMED top ten by weight, 44.1% of the fund, of its 55 equity positions, from the holdings published by its issuer for Nov 18, 2026.

Facts

Holds 55 stocks in healthcare innovation and GLP-1, 60% of its weight in S&P 500 companies · First traded Oct 1, 2020 · Benchmark Its own holdings, as of Nov 18, 2026

Source: ETFIQ, from issuer disclosures, SEC filings and exchange prices. Returns from daily closes, distributions reinvested; each number is dated beside it, and every one is on the fund’s page.Cite as: ETFIQ, BMED Fact Sheet: iShares Health Innovation Active ETF. Data as of Nov 19, 2026. https://etfiq.com/funds/bmed/fact-sheet/ETFIQ is an independent publisher. Not an issuer, broker or adviser. No recommendations. Printed from etfiq.com/funds/bmed.